Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000601921 | SCV000730620 | likely benign | not specified | 2018-01-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000862048 | SCV001002483 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001189423 | SCV001356709 | likely benign | Cardiomyopathy | 2019-10-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448905 | SCV002733909 | likely benign | Cardiovascular phenotype | 2021-02-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004002617 | SCV004844856 | likely benign | Hypertrophic cardiomyopathy | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004704133 | SCV005214406 | likely benign | not provided | criteria provided, single submitter | not provided |